FIELD: pharmacology.
SUBSTANCE: method for determination of methyldope concentration in the human plasma includes sampling of an aliquot of plasma, its deproteinization, the obtained mixture is centrifuged, methyldope concentration is measured in the supernatant by high-performance liquid chromatography with tandem mass spectrometry in the range from 0.020 to 3 mcg/ml by a calibration graph; the difference is in the application of a deuterated internal methyldope standard solution in methanol for plasma deproteinization, chromatographic separation of the matrix components uses two chromatographic columns Phenomenex Luna Phenyl-Hexyl (50×3.0 mm, 5 mcm) and Phenomenex Synergi Fusion-RP 80A (150×4.6 mm, 4 mcm), and the electrospray ionization is performed simultaneously with chemical ionization at atmospheric pressure.
EFFECT: improved method.
1 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINATION OF MYCOPHENOLIC ACID CONCENTRATION IN HUMAN BLOOD PLASMA | 2017 |
|
RU2642288C1 |
METHOD OF QUANTIFICATION OF LEVODOPA IN BLOOD PLASMA | 2017 |
|
RU2665164C1 |
METHOD FOR THE QUANTITATIVE DETERMINATION OF ANTICONVULSANTS IN THE BLOOD PLASMA OF PATIENTS WITH EPILEPSY | 2021 |
|
RU2771430C1 |
METHOD OF DETERMINING CARNOSINE IN BIOLOGICAL MATERIALS | 2015 |
|
RU2585115C1 |
METHOD FOR DETERMINING AMIODARONE AND ITS MAIN METABOLITE DESETHYLAMIODARONE IN HUMAN BLOOD SERUM | 2020 |
|
RU2749566C1 |
METHOD FOR MELDONIUM DETERMINATION IN HUMAN URINE | 2017 |
|
RU2639475C1 |
METHOD FOR MONITORING THE CONTENT OF ANTI-TUBERCULOSIS PREPARATIONS OF THE MAIN LINE AND THEIR TOXIC METABOLITES IN BLOOD PLASMA | 2018 |
|
RU2702998C1 |
METHOD OF QUANTIFICATION OF AMANTADINE IN BLOOD PLASMA | 2017 |
|
RU2650968C1 |
METHOD FOR DETERMINING TOPIRAMATE IN BLOOD PLASMA | 2016 |
|
RU2631613C1 |
METHOD FOR QUANTITATIVE DETERMINATION OF LYCARBAZEPINE IN BLOOD PLASMA | 2017 |
|
RU2660364C1 |
Authors
Dates
2018-01-25—Published
2016-11-07—Filed